S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer

Zhenyan Hou(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoguang Chen(Chinese Academy of Medical Sciences & Peking Union Medical College)
Pharmaceuticals
May 15, 2023
10.3390/ph16050749
Cited by 5

Related Papers

Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype
|Scientific Reports|2017|174
Mechanisms of Triptolide-Induced Hepatotoxicity and Protective Effect of Combined Use of Isoliquiritigenin: Possible Roles of Nrf2 and Hepatic Transporters
|Frontiers in Pharmacology|2018|53
Secreted HSP90α-LRP1 Signaling Promotes Tumor Metastasis and Chemoresistance in Pancreatic Cancer
|International Journal of Molecular Sciences|2022|30
SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling
|International Journal of Molecular Sciences|2023|27
<p>Cryptotanshinone inhibits esophageal squamous-cell carcinoma in vitro and in vivo through the suppression of STAT3 activation</p>
|OncoTargets and Therapy|2019|26